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Development of vasculature and mRNA expression of 17 pro-
or antiangiogenic factors were studied during adipose tissue
development in nutritionally induced or genetically deter-
mined murine obesity models. Subcutaneous (SC) and go-
nadal (GON) fat pads were harvested from male C57Bl/6 mice
kept on standard chow [standard fat diet (SFD)] or on high-fat
diet for 0–15 wk and frommale ob/obmice kept on SFD. Ob/ob
miceandC57Bl/6miceonhigh-fat diet had significantly larger
SC and GON fat pads, accompanied by significantly higher
bloodcontent, increased total bloodvessel volume, andhigher
number of proliferating cells. mRNA and protein levels of
angiopoietin (Ang)-1 were down-regulated, whereas those of
thrombospondin-1 were up-regulated in developing adipose
tissue in both obesity models. Ang-1 mRNA levels correlated
negatively with adipose tissue weight in the early phase of
nutritionally induced obesity as well as in genetically deter-
mined obesity. Placental growth factor and Ang-2 expression
were increased in SC adipose tissue of ob/obmice, and throm-
bospondin-2was increased in both their SC andGON fat pads.
mRNA levels of vascular endothelial growth factor (VEGF)-A
isoforms VEGF-B, VEGF-C, VEGF receptor-1, -2, and -3, and
neuropilin-1 were not markedly modulated by obesity. This
modulation of angiogenic factors during development of ad-
ipose tissue supports their important functional role in
obesity. (Endocrinology 146: 4545–4554, 2005)
IN EARLY STAGE development of adipose tissue, adipo-genesis is tightly associated with angiogenesis (1). Adi-
pose tissue, unlike other organs, grows and develops con-
tinuously throughout life. In vitro studies revealed that
differentiating adipocytes and adipose tissue explants trig-
ger blood vessel formation (2, 3) and that, in turn, adipose
tissue endothelial cells (ECs) promote preadipocyte differ-
entiation (4). Furthermore, adipose tissue growth inmice can
be impaired with angiogenesis inhibitors (5).
Many pro- and antiangiogenic components have been
identified. Vascular endothelial growth factor (VEGF)-A is a
major angiogenic factor that stimulates proliferation and mi-
gration of ECs (6). Three forms of VEGF-A are produced in
the mouse as a result of alternative splicing (VEGF-A121,
VEGF-A165, and VEGF-A189). VEGF-B also promotes an-
giogenesis and is implicated in extracellular matrix degra-
dation via activation of plasminogen (7, 8). VEGF-C plays an
important role both in angiogenesis and lymphangiogenesis
(9). Placental growth factor (PlGF), a VEGF homolog, stim-
ulates angiogenesis in a variety of conditions in vivo and is
a key molecule in regulating the angiogenic switch in patho-
logical conditions (10). The members of the VEGF family
bind to transmembrane tyrosine kinase receptors (VEGF-R1,
VEGF-R2, and VEGF-R3) (11). VEGF-A165, PlGF, and
VEGF-B also bind to another transmembrane receptor, neu-
ropilin (Np)-1. Np-1 functions as an enhancer of VEGF-R2
activation (12), and inactivation of the Np-1 gene causes
disturbances in development of the vascular and nervous
system (13). Fibroblast growth factor (FGF)-2 is also a potent
stimulator of EC proliferation and angiogenesis (14) and
enhances adipocyte differentiation in vivo (15). Another sig-
naling system contributing to vessel maintenance, growth,
and stabilization involves the tyrosine kinase with Ig and
epidermal growth factor homology domains (TIE)-2 recep-
tor, which binds the angiopoietins (Ang)-1 and -2. Unlike
Ang-2, which activates TIE-2 on some cells but blocks it on
others, Ang-1 consistently activates TIE-2. The role of Ang-1
in vascularization is pleiotropic and context-dependent (16).
Ang-1 tightens vessels by affecting junctional molecules (17),
by promoting the interaction between ECs and mural cells
and by recruiting pericytes (18). Ang-2 may stimulate vessel
growth by loosening endothelial-peri-EC interactions and
degrading the extracellular matrix (19). Ang-2 synergizes
with VEGF to stimulate angiogenesis (20); but when insuf-
ficient angiogenic signals are provided, Ang-2 causes EC
death and blood vessel regression (21). Thrombospondins
(TSP)-1 and -2 are matricellular proteins that inhibit angio-
genesis in vivo and impair migration and proliferation of
cultured microvascular ECs (22). Although it is generally
accepted, yet unproven in vivo, that angiogenesis is ongoing
during development of obesity, little is known about the
expression and the role of these different pro- and antian-
giogenic components in adipose tissue.
The aims of this study, therefore, were: 1) to monitor
development of the vascular network in adipose tissue dur-
ing nutritionally induced obesity in mice, 2) to measure
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mRNA levels of pro- and antiangiogenic factors in murine
adipose tissue and to investigate their modulation by diet-
induced or genetically determined obesity, 3) to measure
protein levels ofmodulated factors, 4) to examine the cellular
localization of their expression, and 5) to study expression
patterns during differentiation of murine 3T3-F442A prea-
dipocytes, as in an in vitro model of adipogenesis.
Materials and Methods
Obesity model
Five-week-oldmalewild-type (WT)mice of about 20 g (100%C57Bl/6
genetic background) were kept on a standard chow [4% (wt/wt) fat,
standard fed diet (SFD); KM-04-k12; Muracon, Carfil, Oud-Turnhout,
Belgium] orwere given a high-fat diet (HFD) [21% (wt/wt) fat frommilk
and 49% (wt/wt) carbohydrate from sucrose and corn starch, HFD;
Harlan TD 88137, Zeist, The Netherlands] for 0, 2, 5, or 15 wk (n  12
in each group). The SFD contained 13% kcal as fat with a caloric value
of 10.9 kJ/g, with corresponding values of 42% and 20.1 kJ/g for the
HFD. Nine-week-old male ob/ob mice (n  5) and corresponding WT
mice (n  5) were purchased from Charles River Laboratories, Inc.
(Wilmington, MA). The mice were euthanized with an overdose (60
mg/kg ip) of Nembutal (Abbott Laboratories, North Chicago, IL). In-
traabdominal (gonadal, GON) and inguinal subcutaneous (SC) fat pads
were removed and the wet weight determined. All animal experiments
were approved by the local ethical committee (Katholieke Universiteit
Leuven, P03112) and were performed in accordance with the guiding
principles of the American Physiological Society and The International
Society on Thrombosis and Hemostasis (23).
Measurement of blood content
Blood content of the adipose tissues was quantified using a radio-
labeled tracer (131I-BSA; Draximage, Quebec, Canada). C57Bl/6 mice
after 2, 5, or 15 wk on SFD or HFD (n  7 in each group) were anes-
thetized with a combination of ketamin and xylazine, and a heparinized
catheter was inserted into the jugular vein. After the administration of
2 mg NaI (Sigma, St. Louis, MO), 100 kBq 131I-BSA was injected as a
bolus. Twominutes later, the mouse was killed, and a blood sample was
taken from the tail vein (24). SC and GON fat pads and the blood sample
were weighed, and 131I was counted using a Minaxi 5000 -counter
(Packard Instrument Company, Meriden, CT). The amount of blood in
the adipose tissue was calculated as: (131I-BSA/g tissue)/(131I-BSA/g
blood).
Morphometric and histological analysis
The number of adipocytes and their mean size were determined as
described elsewhere (25). Blood vessels were visualized by staining
10-m paraffin sections with the biotinylated Bandeiraea (Griffonia)
Simplicifolia BSI lectin (Sigma) followed by signal amplificationwith the
Tyramide Signal Amplification Cyanine System (PerkinElmer, Boston,
MA). For each mouse (n 5), at least 12 randomly selected fields in nine
to twelve sections were analyzed by computer-assisted image analysis,
and data were then averaged per animal. The ratio of blood vessel area
to total section area was then normalized to the total adipose tissuemass
to estimate total blood vessel area in the fat pad. Cell proliferation was
evaluated by staining the paraffin sections with anti-Ki-67 antibody
(DakoCytomation, Glostrup, Denmark), amplified with the Tyramide
Signal Amplification Cyanine System. Cell nuclei were visualized by
staining with 4-6-diamidino-2-phenylindole (DAPI, Vector Laborato-
ries, Inc., Burlingame, CA). Colocalization of proliferating cells with ECs
was performed by staining the sections with both lectin and anti-Ki-67
antibody. To avoid aspecific reactions, lectin was visualized with Alexa
568-labeled straptavidin (Molecular Probes, Inc., Eugene, OR), andKi-67
was detectedwith horseradish peroxidase (HRP)-labeled secondary and
tertiary antibody followed by signal amplification with the Tyramide
Signal Amplification Cyanine System. Macrophages were visualized by
staining paraffin sections with anti-Mac-3 antibody (PharMingen, San
Diego, CA), amplified with the Tyramide Signal Amplification Cyanine
System (n  5). Mac-3 positive cells were counted in a blinded way
(staining and counting were performed by two independent observers)
and were expressed as a percentage of the total number of cell nuclei,
determined by DAPI staining, as described above. For each immuno-
staining, a negative control without the primary antibody was also
prepared, which did not show detectable staining (not shown).
Adipose tissue dissociation
SC or GON fat pads dissected from a male ob/ob mouse were used
to separate mature adipocytes from stromal-vascular (S-V) cells, as de-
scribed elsewhere (26). Briefly, minced fat pads were digested with 0.15
mg/ml Liberase Blendzyme 3 (Roche Molecular Biochemicals, India-
napolis, IN) at 37 C for 90 min. Mature adipocytes were separated from
S-V cells by their ability to float upon low-speed (600 g) centrifugation.
The two cell populations were used immediately for RNA extraction. To
monitor EC contamination of the adipocyte fraction, vonWillebrand
factor (vWF) mRNA levels were measured by quantitative real-time
PCR.
Culture and differentiation of 3T3-F442A cells
3T3-F442A preadipocytes were cultured in basal medium: DMEM/
nutrient mix F12 (1:1; Life Technologies, Inc., Merelbeke, Belgium) con-
taining 100 mm pantothenate, 1 mm biotin, 2.5 mm glutamine, 15 mm
HEPES, and supplemented with 10% (vol/vol) fetal bovine serum (Life
Technologies). To induce differentiation, cells were seeded at 3.6  104
cells/cm2 and grown to confluency in basal medium with 10% fetal
bovine serum. Confluent cultures (d 0) were washed in serum-free basal
medium and treated for 5 d with an induction medium: basal medium
supplemented with BSA (100 mg/liter), ITS (10 mg/liter insulin, 5.5
mg/liter transferin, 5 mg/liter selenium; Sigma), 10 nm dexamethasone,
250 mm methylisobutylxanthine, and 1 nm T3. Cultures were then
switched to a differentiation medium (basal medium supplemented
with ITS and T3) for 2 wk (induction and differentiation media were
renewed every 2–3 d). Cellular viability was assessed by cell counting,
Trypan Blue dye exclusion assay, and WST-1 (Roche Molecular Bio-
chemicals) assay as described previously (27). To assess the extent of
preadipocyte differentiation, cytosolic triglyceride content was quanti-
fied by determining Nile Red uptake, as monitored by flow cytometric
analysis (FACSCalibur; Becton Dickinson, San Jose, CA), and the ex-
pression profile of several preadipocyte and adipocyte markers [prea-
dipocyte factor-1, peroxisome proliferator-activated receptor (PPAR)-,
and glycerophosphate dehydrogenase] was determined (28). 3T3-F442A
cells were differentiated in two independent experiments.
RNA isolation
SC and GON fat pads were homogenized using lysing matrix tubes
(Qbiogene, Carlsbad, CA) in a Hybaid ribolyzer (Thermo, Waltham,
MA). Total RNA was extracted from homogenized adipose tissues,
isolated adipocytes, S-V cells, and 3T3-F442A cells using the RNA Easy
Qiagen Kit (QIAGEN, Valencia, CA) and treated with ribonuclease free
deoxyribonuclease (QIAGEN) according to the manufacturer’s instruc-
tions. Integrity of extracted RNAwas validated from the intensity of 18S
and 28S ribosomal RNA bands on agarose gels. RNA concentrations
were measured using the RiboGreen RNA quantification kit (Molecular
Probes). RNA samples were diluted in water and stored at 80 C. To
investigate the expression of pro- and antiangiogenic factors in vivo, an
initial screening was performed. Therefore, adipose tissue samples were
divided into 16 groups (SC or GON adipose tissue from mice on 2, 5, or
15 wk on SFD or HFD and SC or GON adipose tissue fromWT or ob/ob
mice). After extracting total RNA, the same amount of RNAwas pooled
from adipose tissues in the same group; thus 16 RNApoolswere created.
The expression profile of pro- and antiangiogenic factors was first mea-
sured in these pools, and the mRNA levels of factors that were mod-
ulated at least by 2-fold in both obesity models (i.e. Ang-1 and TSP-1)
were subsequently determined in individual samples. For prescreening,
the samples were analyzed in triplicate, and the whole analysis was
repeated two times.
Oligonucleotide primers and probes
The design of oligonucleotide primers and probes specific for the
different targets (Table 1) was described elsewhere (25). Briefly, sense
4546 Endocrinology, October 2005, 146(10):4545–4554 Voros et al. • Angiogenesis in Adipose Tissue
and antisense primers (Eurogentec, Seraing, Belgium) annealing to dis-
tinct exons were selected, and different concentrations of the primer
pairs were first tested on positive control RNA samples. Primers were
always used in concentrations to yield only one band of the correct size
as demonstrated on polyacrylamide gels. The amplified DNA was se-
quenced and was found to be correct for all targets.
Quantitative real-time PCR (RT-PCR)
mRNA expression levels were determined by quantitative RT-PCR.
Reverse transcription reactions were performed from 200 ng total RNA
at 48 C during 60 min with the Taqman Reverse Transcription Kit and
5 m random hexamers (Applied Biosystems). Quantitative RT-PCR
was performed in the ABI-prism 7700 sequence detector using the Taq-
man PCR core reagents kit (Applied Biosystems). Samples containing
the highest amount of each target were used to create standard curves
(10-, 20-, 40-, 80-, 320-, and 1280-fold dilution of the transcribed cDNA).
All of these standard curves were linear, with r2 values more than 0.98.
In the same run, CT values of the samples (20-fold diluted cDNA) were
measured, and relative expression levels were determined. As a house-
keeping gene, the expression of 18S ribosomal RNAwasmeasured in the
same way, using the Taqman Ribosomal RNA Control Kit (Applied
Biosystems) according to the manufacturer’s protocol [18S ribosomal
RNA (rRNA) levels were relatively stable across different samples; dif-
ferences were always less than 20%]. The mRNA levels of the targets
were normalized to those of 18S for each sample. PCR amplifications
were performed in duplicatewells, using the following conditions: 2min
at 50 C and 10 min at 94 C followed by 40 two-temperature cycles (15
sec at 95 C and 1 min at 60 C).
Immunoprecipitation and immunoblotting
Because Ang-1 antigen levels were undetectable with standardWest-
ern blotting, we concentrated the antigen by immunoprecipitation. SC
andGON adipose tissues were homogenized in a lysis buffer (10mmNa
phosphate, 150 mm NaCl; pH 7.2) containing 0.2% Na azide and a
complete protease inhibitor cocktail (Roche Molecular Biochemicals),
followed by incubation with detergents (1% Triton X-100, 0.1% sodium
dodecyl sulfate, 0.5% Na deoxycholate) for 2 h at 4 C. Protein concen-
trations were measured with the BCA protein assay (Pierce Biotechnol-
ogy, Rockford, IL) according to the manufacturer’s protocol.
Protein extracts (1 mg protein) were incubated with 5 g polyclonal
goat anti-Ang-1 antibody (N-18; Santa Cruz Biotechnology, Inc., Santa
Cruz, CA) overnight, followed by an additional overnight incubation
with Protein G Sepharose beads (Amersham Pharmacia Biotech, Upp-
sala, Sweden). After washing the beads three times with PBS containing
a complete protease inhibitor cocktail, Ang-1 was eluted with sample
buffer containing 20 mm 2-mercaptoethanol and boiled for 8 min. Sam-
ples were loaded on 10% sodium dodecyl sulfate-polyacrylamide gels.
After electroblotting, nitrocellulose membranes were blocked with 5%
milk powder in Tris-buffered saline (TBS) (TBS-Tween containing 150
mmNaCl, 10 mm Tris, 0.05% Tween 20; pH 7.5) for at least 1 h. After an
overnight incubation with anti-Ang-1 antibody, membranes were
washed with TBS-Tween and incubated with HRP-labeled rabbit anti-
goat secondary antibody (1:2000; DakoCytomation) for 2 h. Protein
bands were detected using the enhanced chemiluminescence plus de-
tection kit (Amersham Biosciences, Little Chalfont, UK) and expressed
as relative units (RU) after background correction.
ELISA
A home-made ELISAwas used to measure TSP-1 protein levels in SC
and GON adipose tissue extracts. Ninety-six-well plates (Costar, Cam-
bridge,MA)were coatedwith amonoclonalmouse anti-TSP-1 antibody,
followed by incubation of samples and standards. Bound TSP-1 was
labeled with a biotinylated monoclonal mouse anti-TSP-1 antibody and
HRP-labeled streptavidine, followed by a color reaction with o-phen-
ylenediamine. Mouse TSP-1 was obtained by lysing platelet-rich plasma
with 1% triton in PBS and was used to make a standard dilution curve.
The results are expressed as percentage of the undiluted platelet lysate
(linear range of the standard curve between 0.33 and 0.015% of the
undiluted platelet lysate). The interassay coefficient of variation was
8.9%, and the intraassay coefficient of variation was 3.4%. The dilution
curves of the platelet lysate and the samples were parallel (not shown).
Statistical analysis
Data are reported as mean  sem. Statistical significance between
groups is evaluated using nonparametric t testing. Correlations are
examined using the nonparametric Spearman’s rank correlation coeffi-
cient. The threshold for significance is set at P  0.05.
Results
Increased vascularization in fat pads of obese mice
C57Bl/6 mice kept on HFD for 2, 5, or 15 wk had a sig-
nificantly higher total body weight than age-matched mice
on SFD (26.4  0.6 vs. 21.1  0.7 g after 2 wk, 32.9  0.9 vs.
25.4 0.4 g after 5 wk, and 46.3 1.77 vs. 30.0 0.62 g after
15 wk, all P  0.001), and the weight of their SC and GON
adipose tissues was significantly higher (Table 2). Analysis
of SC and GON adipose tissue sections showed that the
average adipocyte area was significantly increased in mice
fed a HFD. The blood mass/tissue mass ratios, evaluated
from in vivo distribution of 131I-BSA, were lower in obese,
TABLE 1. Sequence of primers and probe (5–3) used for the RT-PCR assays
mRNA species Sense Probe Antisense
Ang-1 CAACAACAACAGCATCCTGCA AAGCAACAACTGGAGCTCATGGACACAGT TGCAAAGGCTGACAAGGTTATG
Ang-2 CTGTGCGGAAATCTTCAAGTCA CACCAGTGGCATCTACACACTGACCTTCC CCTTGATCTCCTCTGTGGAGTTG
TIE-1 ACCTGTGCTGAGCTCTACGAGAA CTATCGCATGGAGCAGCCTCGAAACTG CATCAGCTCGTACACTTCGTCAT
TIE-2 AACCAACAGTGATGTCTGGTCCTAT TGCCTCCTAAGCTAACAATCTCCCAGAGCAATA GCACGTCATGCCGCAGTA
VEGF-A 121 TGCAGGCTGCTGTAACGATG TGTCTTTCTTTGGTCTGCATTCACATCGG CCTCGGCTTGTCACATTTTTCT
VEGF-A 165 TGCAGGCTGCTGTAACGATG TGTCTTTCTTTGGTCTGCATTCACATCGG GAACAAGGCTCACAGTGATTTTCT
VEGF-A 189 TGCAGGCTGCTGTAACGATG TGTCTTTCTTTGGTCTGCATTCACATCGG CTCCAGGATTTAAACCGGGATT
VEGF-B TGCCATGGATAGACGTTTATGC CGTGCCACATGCCAGCCCA TGCTCAGAGGCACCACCAC
VEGF-C AAGACCGTGTGCGAATCGA AAAGGACAGTCCTGGATCACAATGCTTCA ACACAGCGGCATACTTCTTCAC
VEGF-R1 TGGCCAGAGGCATGGAGT TCTGTCCTCCAGAAAGTGCATTCATCGG TCGCAAATCTTCACCACATTG
VEGF-R2 GGAGAAGAATGTGGTTAAGATCTGTGA CATCTCCTTTTCTGACATAATCCGGGTCTTTATAAATGTC ACACATCGCTCTGAATTGTGTATACT
VEGF-R3 GGTTCCTGATGGGCAAAGG CGGCGAGCCCCACTTGTCCA TCAGTGGGCTCAGCCATAGG
PIGF TTCAGTCCGTCCTGTGTCCTT ACCACAGCAGCCACTACAGCGACTCA GCACACAGTGCAGACCTTCA
FGF-2 GCGACCCACACGTCAAACTA TGTGCCAACCGGTACCTTGCTATGAAG AGCCAGCAGCCGTCCAT
Np-1 ACACCTGAGCTTCGGACGTT TCACCTCTCTCCACAAGGTTCATCAGGATC CCACTGTGTGTGGCTCTCTCA
TSP-1 AACAAAGGACCTCCAAGCTATCTG TGCGCACCATCGTGACCACTCTG GGGAGGCCGCTTCAGC
TSP-2 GAGCTCTCTGGACTGCACGTC GACACTCTCTCCAGGTTCTTGCTCAGCTG TTTCATTTTCTGCAAAGATTCGG
vWF GCATCTACGGCGCTATCATGTAT TTGGCCACATCCTCACATACACGCC TGTGGTGACCGTGCCATCT
PPAR- CTGTCGGTTTCAGAAGTGCCT CCCAAACCTGATGGCATTGTGAGACA ATCTCCGCCAACAGCTTCTC
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compared with lean, adipose tissues (not shown), but the
total amount of blood was significantly higher (Table 2). The
total blood content of SC or GON fat pads frommice on SFD
or HFD correlated well with the adipose tissue mass [both
rho () 0.9 with P 0.000001]. Staining of blood vessels in
the adipose tissue sections showed a smaller vessel size and
lower vessel density in tissues of obese mice, but a positive
correlation was observed between the total blood vessel area
and SC or GON fat pad mass when data on SFD and HFD
were pooled (  0.34 with P  0.074 for SC adipose tissue,
and   0.79 with P  0.000001 for GON adipose tissue).
Staining with an anti-Ki-67 antibody revealed that the ratio
of proliferating cells was significantly increased in SC and
GON adipose tissue sections frommice onHFD for 2 wk, but
not for 5 or 15 wk, compared with mice on SFD (Table 2).
Double staining revealed that Ki-67-positive nuclei colocal-
ize with lectin-positive ECs (Fig. 1). Staining of macrophages
with an anti-Mac-3 antibody showed that the ratio of mac-
rophages to total number of cell nuclei was significantly
higher in all adipose tissue sections from obese, compared
with lean,mice (Table 2); it correlatedpositivelywith adipose
tissue mass (  0.87 with P  0.0001 for SC adipose tissue,
and   0.91 with P  0.0001 for GON adipose tissue).
Genetically obese ob/ob mice kept on SFD also had a
significantly higher total body weight (41  1.2 vs. 27 
0.62 g), SC (1600  47 vs. 150  16 mg), and GON adipose
tissue mass (2800  260 vs. 270  30 mg, all P  0.001),
compared with the WT mice. Blood vessel density (1/mm2)
in their adipose tissues was significantly decreased (430 20
vs. 1200  100, P  0.01 for SC adipose tissue, and 390  21
vs. 830  87, P  0.05 for GON adipose tissue), but the total
blood vessel area in the whole fat pad was significantly
TABLE 2. Composition of SC and GON adipose tissues from C57Bl/6 mice kept on SFD or HFD for 2–15 wk
Weeks
SFD HFD
SC GON SC GON
2 5 15 2 5 15 2 5 15 2 5 15
Fat pad weight
(mg)
180 8.8 210 14 350 56 180 18 280 19 590 94 490 35a 800 66a 1300 110a 670 44a 1200 93a 1600 62a
Adipocyte size
(m2)
280 14 340 31 370 40 360 28 570 20 650 48 650 50a 830 110a 1300 46a 940 39a 1300 130a 2200 38a
Blood vessel size
(m2)
92 7.6 74 5.5 49 2.8 52 1.9 50 2.6 49 3.4 62 4.4a 48 2.8a 46 2.5 48 2.2 41 1.8a 54 3.3
Blood vessel density
(l/mm2)
1600 57 1400 100 1400 100 1200 55 850 40 790 41 1000 44a 770 51a 740 30a 790 30a 410 20a 490 19a
Blood mass (mg) 6.7 0.36 7.6 0.50 7.3 0.73 8.6 1.2 9.4 0.90 9.2 1.0 8.4 0.35a 13 0.95a 19 1.8a 14 1.7a 27 2.5a 28 2.0a
Proliferating cells
(%)
2.2 0.63 1.9 0.38 2.2 0.29 3.7 0.47 2.8 0.61 2.2 0.67 7.0 1.3a 4.9 1.8 2.6 0.49 9.0 1.5a 4.5 0.86 3.8 0.69
Macrophages (%) 7.1 0.79 7.0 0.54 7.2 0.56 8.1 1.2 10 0.91 11.2 1.0 11 1.2a 14 1.5a 13 3.0a 13 0.64a 15 1.9a 18 3.3a
Data are mean  SEM.
a P  0.05 vs. SFD.
FIG. 1. Double staining of SC or GON adipose tissue with Bandeiraea Simplicifolia lectin and anti-Ki-67. A, Lectin staining; B, anti-Ki-67
staining; C, autofluorescence of the tissue; D, DAPI staining; E, superposition.
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increased, compared with WT mice. A positive correlation
was observed between the total blood vessel area and SC or
GON fat pad mass (  0.77 with P  0.01 for SC adipose
tissue, and  0.93 with P 0.001 for GON adipose tissue).
The macrophage content was significantly higher in adipose
tissues of ob/ob, comparedwithWT,mice (17 0.99 vs. 5.1
0.43% for SC and 27  2.1 vs. 6.7  0.87% for GON adipose
tissue; both P  0.001).
Adipose tissue expression of pro- and antiangiogenic
molecules
The expression pattern of 17 transcripts of interest in-
volved in angiogenesis was first investigated in the RNA
pools of SC andGON adipose tissue fromC57Bl/6mice kept
on SFD or HFD for 2, 5, or 15 wk (Table 3). The expression
of pro- and antiangiogenic factors was relatively constant in
adipose tissue samples from mice on SFD (not shown), with
the exception of Ang-1 and TSP-1 (see below). Ang-1 was
down-regulated in SC adipose tissue after 5 wk of HFD and
in GON adipose tissue after 2 and 5 wk, compared with mice
kept on SFD for the same duration. The expression patterns
of Ang-2 and TIE-2 did not show marked modulation. TIE-1
mRNA levels were 1.8-fold higher in the SC adipose tissue
after 2 and 15 wk onHFD. The expression of TSP-1 wasmore
than 2-fold higher in both fat pads after 5 wk on HFD but
showed a down-regulation after 2 wk in the GON adipose
tissue and after 15 wk in both adipose tissues. TSP-2 mRNA
levels in SC tissues were stable during the diet but increased
in GON tissues. The three isoforms of VEGF-A, VEGF-B,
VEGF-C, the three VEGF receptors, Np-1, and PlGF did not
show marked modulations. The expression of FGF-2 was
overall lower in HFD than in SFD samples, most obviously
in SC adipose tissue after 5 wk. The mRNA levels of these
proteins were also measured in the adipose tissue of 9-wk-
old ob/ob and correspondingWTmice (Table 3). Ang-1 was
also strongly down-regulated in both SC and GON adipose
tissues of ob/ob, compared with WT, mice. Ang-2 mRNA
levelswere increasedmore than 2-fold in SC, but not inGON,
adipose tissue, and the expression of TIE-1 and TIE-2 re-
mained unaltered. The VEGF family members, VEGF recep-
tors, FGF-2, andNp-1mRNA levels were notmarkedlymod-
ulated, albeit sometimes decreased. PlGF expression was
2-fold up-regulated in SC adipose tissue. TSP-1mRNA levels
were 5-fold increased in SC adipose tissue, whereas TSP-2
expression was 2-fold increased in both adipose tissues of
ob/ob mice. PPAR-mRNA levels were not markedly mod-
ulated in SC or GON adipose tissue by either nutritionally
induced or genetically determined obesity (Table 3).
The mRNA levels of Ang-1 and TSP-1, the two targets
modulated at least 2-fold in both obesity models, were sub-
sequently measured in individual samples from both diet
studies. This confirmed the expression pattern seen in the
initial screening (Fig. 2). Compared with mRNA levels in
5-wk-old C57Bl/6mice on SFD (wk 0), Ang-1 expressionwas
down-regulated in SC adipose tissue after 15wk and inGON
adipose tissue after 2, 5, and 15 wk in mice on SFD (Fig. 2A).
In mice fed a HFD, Ang-1 mRNA levels were down-regu-
lated in both adipose tissues after 2, 5, and 15 wk, compared
with wk 0. Furthermore, Ang-1 mRNA levels were signifi-
cantly lower in SC adipose tissue after 5 wk and in GON
adipose tissue after 2 and 5 wk onHFD, compared with SFD.
TSP-1 expressionwas up-regulated in SC adipose tissue after
15wk and inGONadipose tissue after 2, 5, and 15wk inmice
on SFD, compared with 5-wk-old mice (Fig. 2B). In mice fed
a HFD, TSP-1 mRNA levels were up-regulated in both ad-
ipose tissues after 5 and 15 wk, compared with wk 0. TSP-1
mRNA levels were significantly lower in SC adipose tissue
after 15 wk, in GON adipose tissue after 2 and 15 wk, but
significantly higher in both adipose tissues after 5 wk on
HFD, compared with SFD. Expression of Ang-1 was down-
regulated in SC and GON adipose tissue and that of TSP-1
up-regulated in SC adipose tissue of ob/ob, compared with
TABLE 3. Expression of pro- and antiangiogenic molecules and PPAR- in SC and GON adipose tissue of mice
Weeks
C57Bl/6a ob/obb
SC GON SC GON
2 5 15 2 5 15 9 9
Ang-1 73 43 96 22 48 71 35 16
Ang-2 134 76 111 118 86 120 225 75
TIE-1 182 110 183 101 94 140 130 110
TIE-2 86 74 129 94 111 135 89 61
VEGF-A 121 103 99 85 94 108 95 79 52
VEGF-A 165 92 74 75 79 76 84 79 55
VEGF-A 189 97 80 90 108 106 116 92 74
VEGF-B 89 61 97 125 101 81 75 54
VEGF-C 99 68 173 105 99 120 143 97
VEGF-R1 95 52 95 95 96 107 49 79
VEGF-R2 78 66 89 104 87 74 105 43
VEGF-R3 109 76 106 77 62 99 179 87
PIGF 154 81 73 99 82 122 218 96
FGF-2 79 36 64 82 70 55 87 59
Np-1 111 104 95 84 79 92 116 72
TSP-1 86 272 30 35 215 37 518 99
TSP-2 127 111 114 61 103 179 180 229
PPAR- 137 79 143 89 108 87 130 109
a mRNA expression level relative to the SFD (100%).
b mRNA expression level relative to WT mice (100%).
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WT, mice (Fig. 3). Ang-1 mRNA levels correlated negatively
with adipose tissue weights in the early phase of nutrition-
ally induced obesity. In SC adipose tissue, the correlationwas
significant after 2 and 5 wk (  0.39 with P  0.01) and
inGONadipose tissue after 2wk (0.88withP 0.0001).
Ang-1 expression did not change between 5 and 15 wk in SC
adipose tissue and between 2 and 15 wk in GON adipose
tissue from mice on HFD, and no correlation was found
between tissue weights and Ang-1 expression in this later
phase. Adipose tissue weights showed significant negative
correlations with Ang-1 mRNA levels in genetically deter-
mined obesity (0.72with P 0.02 for SC adipose tissue,
and   0.75 with P  0.02 for GON adipose tissue).
Protein levels of Ang-1 and TSP-1 in obesity
Ang-1 protein levels were generally compatible with the
mRNA expression pattern (Fig. 2A). In nutritionally induced
obesity, protein levels were lower in both adipose tissues of
mice after 2, 5, and 15 wk on SFD or HFD, compared with
wk 0. In accordance with significant differences in mRNA
levels, lower Ang-1 protein levels were found in SC adipose
tissue after 5 wk and in GON adipose tissue after 2 and 5 wk
on HFD, compared with SFD. TSP-1 protein expression in
mice on SFD (Fig. 2B) was significantly increased in SC and
GONadipose tissue after 15wk, comparedwithwk0. Inmice
fed a HFD, TSP-1 protein levels were significantly higher in
SC adipose tissue after 5 and 15 wk and in GON adipose
tissue after 2, 5 and 15 wk, compared with wk 0. TSP-1
protein levels inmice onHFDwere lower in the SC andGON
adipose tissue after 15 wk but higher in GON adipose tissue
after 2 and 5 wk, compared with SFD. Also in genetically
determined obesity, Ang-1 protein levels were lower and
TSP-1 protein levels significantly higher in both SC andGON
adipose tissue of ob/obmice, comparedwithWTmice (Fig. 3).
FIG. 3. mRNAand protein levels of Ang-1 (A) andTSP-1
(B) in genetic obesity. mRNA and protein levels were
measured in SC and GON adipose tissue of 5 WT (white
bars) or ob/ob (black bars) mice; mRNA levels were nor-
malized to 18S rRNA, and protein levels were expressed
in RU. *, P  0.05; **, P  0.01 and ***, P  0.001 vs.
WT. Data are mean  SEM, with the exception of Ang-1
protein levels that were measured by immunoprecipi-
tation and Western blotting on pooled samples.
FIG. 2. mRNA expression and protein level of Ang-1 (A)
andTSP-1 (B) in nutritionally induced obesity.Mice (n
12) were kept on SFD (white bars) or HFD (black bars)
for 0–15 wk. mRNA and protein levels were measured
in SC and GON adipose tissue; mRNA levels were nor-
malized to 18S rRNA, and protein levels were expressed
in RU. *, P  0.01 and **, P  0.001 vs. SFD. Data are
mean  SEM, with the exception of Ang-1 protein levels
that were measured by immunoprecipitation and West-
ern blotting on pooled samples.
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Cellular localization
The expression patterns of the targets thatweremodulated
in the two obesity models and of those expected to be se-
lectively expressed were investigated in the separated cell
populations. Ang-1, Ang-2, PlGF, TSP-1, and -2mRNAswere
detected in both cell fractions. TIE-1 was mainly expressed
by S-V cells and by somemature adipocytes, especially in SC
adipose tissue. TIE-2 and the three VEGF receptors were
nearly exclusively expressed by the S-V cells in both SC and
GON adipose tissues (Fig. 4). Low expression levels of vWF
(ranging from 2–7% of those observed in the corresponding
S-V fractions) were detected in the mature adipocyte frac-
tions, indicating the presence of a low number of contami-
nating ECs (29).
Expression during in vitro adipogenesis
Differentiation of 3T3-F442A preadipocytes resulted in the
appearance of cells characterized by higher intensities ofNile
Red fluorescence (indicating intracellular lipid accumula-
tion) detected at 530 nm (Fig. 5). mRNA levels of preadipo-
cyte factor-1 decreased, whereas the expression of PPAR-,
a marker of early differentiation, and that of glycerophos-
phate dehydrogenase, a marker of late differentiation, in-
creased (data not shown). mRNAs for Ang-1, the VEGF-A
isoforms, and PlGF showed an up-regulation during adipo-
cyte differentiation. FGF-2 and Np-1 expression were tran-
siently up-regulated, whereas the expression of Ang-2 was
high in confluent cultures but decreased as adipocytes ma-
tured. TSP-1 and TSP-2 expression was down-regulated 5 d
after induction but increased again during further differen-
tiation. VEGF-B, VEGF-C, and VEGF-R1 mRNA levels were
less modulated. TIE-1, TIE-2, VEGF-R2, and VEGF-R3 were
not expressed at detectable levels by the 3T3-F442A cells.
Discussion
Modulation of development of the vascular network in
adipose tissue may constitute a strategy to affect obesity (2).
Therefore, it is important to obtain information on expression
and functional role of pro- and antiangiogenic components.
In this study, we characterized some aspects of blood vessel
development in nutritionally induced or genetically deter-
mined murine models of obesity. We found that the total
blood content of the SC and GON fat pads correlated well
with the adipose tissue mass. Different morphological or
functional changes of the vasculature can account for this
observation. One possible explanation is that the perfusion
of the tissue increases due to vasodilatation and opening of
preexisting, but nonperfused, capillaries. In a previous
study, increased perfusion and decreased vascular resistance
were shown in SC and GON fat pads of obese, compared
with lean, rats (30). Blood vessel staining confirmed a pos-
itive correlation between fat pad mass and the total blood
vessel area in both obesitymodels, supporting the hypothesis
that the increased blood content of obese adipose tissue is not
only the consequence of functional modulations of the vas-
culature but is also caused by growth of the vascular net-
work. To identify factors involved in adipose tissue-related
angiogenesis, the expression pattern of 17 pro- or antiangio-
genic molecules was monitored. Adipose tissue develop-
ment is a partly physiological and a partly pathological pro-
cess.On the basis of previously publisheddata, the genes that
we studied are likely to play crucial roles in both physio-
logical and pathological angiogenesis (6, 7, 10).
Ang-1 expression was significantly down-regulated in SC
fat pads after 5 wk and in the GON adipose tissue after 2 and
5 wk on HFD vs. SFD. A significant negative correlation was
found between Ang-1 mRNA levels and adipose tissue mass
in the early phase of nutritionally induced and in genetically
determined obesity. Ang-1 protein levels, measured in both
obesity models, were overall compatible with mRNA ex-
pression. In a recent study, reduced Ang-1 expression was
reported in mice losing weight, and an inverse correlation
was found between Ang-1 mRNA levels and the rate of
weight change, independent of the direction (31). In our
study Ang-1 mRNA and protein expression were decreased
(compared with wk 0) in the early phase of nutritionally
induced obesity, when mice gained weight faster, and they
further decreased in the fat pads of mice on SFD between 5
and 15 wk. Ang-1 mRNA and protein levels were consid-
erably lower, compared with wk 0 (especially in GON adi-
pose tissue) in mice after 15 wk on both SFD and HFD, when
the body weight was stable. These data support the concept
that Ang-1 mRNA levels are not merely regulated by weight
change in developing or regressing adipose tissue. Lower
Ang-1 levels may result in increased plasticity of vessels,
FIG. 4. Cellular localization of mRNA in isolated adi-
pocytes (black bars) expressed relative to the S-V cells
(white bars) derived from SC and GON adipose tissue
(ob/ob genetic background).
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increased vascular permeability, and smaller lumen diame-
ters, which all characterize the vasculature of obese adipose
tissue. There are similarities, but also clear differences, be-
tween TSP-1 mRNA and protein expression patterns both in
nutritionally induced and genetically determined obesity
(Figs. 2B and 3B). This different regulation may be due to
translational regulation of TSP-1 expression or differences in
its degradation (32).
The opposite modulation of Ang-1 (down-regulated) and
TSP-1 (up-regulated) expression during adipose tissue de-
velopment may have a common mechanism. Indeed, inhi-
bition of TIE-2 signaling in vitro has been shown to up-
regulate TSP-1 in ECs (33).
TSP-1 is mainly expressed by intraabdominal adipose tis-
sue of rats and humans (34, 35). In this study, we found that
TSP-1 expression was strongly modulated by the degree of
obesity and was mainly observed in GON adipose tissue
after 2 and 5 wk on HFD and in the WT littermates of ob/ob
mice. Gene expression is differently regulated in SC and
GON adipose tissues. This may be explained by the fact that
SC and GON fat pads have substantially different charac-
teristics. In humans, it is well established that accumulation
of intraabdominal adipose tissue is a higher risk factor for
vascular complications than the SC fat pad (36). They pro-
duce different amounts of plasminogen activator inhibitor
(PAI)-1, PAI-2, leptin, ILs, and TSP-1 (37). Inmice, after 5 wk,
the growth rate of GON adipose tissue is generally slower,
comparedwith SC adipose tissue. These differencesmight all
contribute to the different regulations of angiogenic factors
in different fat pads. However, there are factors (Ang-1) that
are similarly regulated in the distinct fat pads of the different
models.
TSPs are known antiangiogenic factors; and, when the
growth rate of adipose tissue stabilizes, their higher expres-
sion may limit further blood vessel formation. TSPs are ex-
pressed by 3T3-F442A cells and are down-regulated after
induction of differentiation, followed by a later up-regula-
tion. A similar expression pattern was found in NIH-3T3 (38)
and in 3T3-L1 (39) cells during differentiation into adipo-
cytes; in other studies, however, TSP-1 was shown to be
up-regulated 1–3 h after induction of differentiation in
3T3-F442A (40) and 3T3-L1 (41) preadipocytes. Whether a
higher amount of TSPs produced by differentiated adipo-
cytes only has an impact on vascular elements or, in an
autocrine manner, on the adipocytes themselves needs
further investigation.
The expression of Ang-2 and TIE-2 remained relatively
constant in the two in vivo obesity models, except for a 2-fold
up-regulation of Ang-2 in the SC adipose tissue of ob/ob
mice (Table 3). This may be important for the intensive mod-
ulation of vasculature in the developing adipose tissue of
ob/ob mice, because Ang-2 is often expressed together with
VEGF-A at sites of neoangiogenesis (42). In our study, the
expression of VEGF-A isoforms, VEGF-B, VEGF-C, and the
three VEGF receptors was not markedly modulated in either
obesity model. Still, adipose tissue and mature adipocytes
are known to produce high amounts of VEGF-A (43). A
recent study in overweight and obese male subjects did not
show significant modulation of the serum concentration of
VEGF or Ang-2 (44). Both VEGF-AmRNA and protein levels
were found to be higher in 14-wk-old, compared with 6-wk-
old, db/db mice and in obese KK-AY mice, compared with
WT mice (45). The difference with our results may be ex-
plained by differences in the experimental conditions. First,
in our experiments, we used the nutritionally induced mu-
rine obesitymodel and studied ob/ob andWTmice, inwhich
regulation of VEGF-A expressionmight be different. Second,
we normalized VEGF-A expression to 18S rRNA levels and
not to -actinmRNA. -actin is significantly down-regulated
in obese, comparedwith lean, SC adipose tissue from human
FIG. 5. Expression of angiogenic factors dur-
ing in vitro adipogenesis. Total RNA was ex-
tracted from 3T3-F442A cells at different
stages of differentiation: Pre, preconfluent;
Con, confluent (d 0); d5, d12, and d19, post-
confluent cultures after 5, 12, and 19 d, re-
spectively. mRNA levels were normalized to
18S rRNA. Intracellular lipid accumulation
during preadipocyte differentiation, as moni-
tored by the intensity of Nile Red fluorescence,
is also shown. White bars represent mRNA
levels obtained in one experiment, and total
bars (white plus black) representmRNA levels
from a second experiment.
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subjects (46). If this is also the case in murine models of
obesity, normalization of mRNA or protein levels to -actin
might result in a wrong interpretation. In our samples the
expression of 18S rRNA was very similar in all samples
investigated. Further in vivo studies with inhibition of VEGF
receptors will be required to elucidate the exact role of VEGF
in obesity. FGF-2 was generally down-regulated in nutri-
tionally induced and genetic obesity but up-regulated in
differentiating 3T3-F442A cells. These data differ from a
study showing higher FGF-2 mRNA levels in massively
obese humans, compared with lean ones (47), possibly due
to the fact that, in our in vivo models, obesity mainly results
from adipocyte hypertrophy, whereas in massively obese
persons, adipocyte hyperplasia may also occur. In the latter
case, increased levels of FGF-2, an enhancer of adipocyte
differentiation, may be more relevant.
Regulation of mRNA expression of some pro- and anti-
angiogenic factors was considerably different between the
two diet models. For example, expression of Ang-2 and PlGF
was up-regulated in the SC adipose tissue, and that of
VEGF-R2 was down-regulated in the GON adipose tissue of
ob/ob, compared with WT, mice, but it was unchanged in
nutritionally induced obesity. Leptin-deficiency apparently
results in faster adipose tissue formation and a higher degree
of obesity than the HFD used in this study. The observed
differences may be explained by the enhanced adipose tissue
formation or by the lack of leptin itself, which has been found
to affect the expression of several angiogenic components
(48).
It is increasingly recognized that macrophages are playing
a role in adipose tissue development. As reported in other
studies (49), we found a strong correlation between the mac-
rophage content and the adipose tissue mass in our in vivo
models. Because these immune cells produce angiogenic fac-
tors and are abundant in adipose tissue, they may signifi-
cantly contribute to the enlargement of the tissue
vasculature.
Hypoxia may be increased during adipose tissue devel-
opment, which, in turn, would trigger blood vessel forma-
tion. Several mRNAs induced by hypoxia (PAI-1, TSP-1) are
increased in obesity. On the other hand, the expression of
VEGF isoforms, which are also strongly induced by hypoxia
and leptin, is unchanged in our in vivo samples. Thus, if there
is hypoxia during adipose tissue development, it only stim-
ulates the expression of a limited number of targets; VEGF
expression is clearly also regulated by additional factors.
In summary, in nutritionally induced or genetic obesity in
mice, fat pad growth is accompanied by increased vascular-
ization. During adipose tissue development, Ang-1 is mark-
edly down-regulated, whereas TSP-1 is up-regulated in SC
and GON adipose tissue. Less extensive modulations were
found in PlGF, TSP-2, and FGF-2 mRNA levels. Expression
of other VEGF family members and Np-1 was not markedly
changed in these obesity models. These findings do not ex-
clude the possibility that modifying VEGF signaling may
have an effect on adipose tissue development, but suggest a
potential role for other pro- and antiangiogenic factors in
obesity-related angiogenesis. Further studies are required to
elucidate their functional role in obesity.
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